Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Joy Schechtman"'
Autor:
Aaron Broadwell, Joy Schechtman, Douglas Conaway, Alan Kivitz, Natalie J. Shiff, Shawn Black, Stephen Xu, Wayne Langholff, Sergio Schwartzman, Jeffrey R. Curtis
Publikováno v:
BMC Rheumatology, Vol 7, Iss 1, Pp 1-13 (2023)
Abstract Background Biologic therapies are often prescribed for patients with rheumatoid arthritis (RA) who have inadequate responses to or are intolerant of methotrexate (MTX) and patients with poor prognostic indicators. This post hoc analysis eval
Externí odkaz:
https://doaj.org/article/c660845ad6064916b2d9ab800648486d
Autor:
Douglas Conaway, Alan Kivitz, Vance Bray, Wayne Langholff, Stephen Xu, D. Parenti, Joy Schechtman, Aaron Broadwell, S. Kafka, Shawn Black
Publikováno v:
SATURDAY, 15 JUNE 2019.
Background AWARE (Comparative and Pragmatic Study of Golimumab IV Versus Infliximab in Rheumatoid Arthritis) is an ongoing Phase 4 comparator study designed to provide a real-world assessment of intravenous golimumab (GLM) and intravenous infliximab
Autor:
Atul Deodhar, Lianne S. Gensler, Joachim Sieper, Michael Clark, Cesar Calderon, Yuhua Wang, Yiying Zhou, Jocelyn H. Leu, Kim Campbell, Kristen Sweet, Diane D. Harrison, Elizabeth C. Hsia, Désirée Heijde, Frederico Ariel, Cecilia Adma Asnal, Alberto Berman, Gustavo Citera, Graciela Rodriguez, Veronica Gabriela Savio, Paul Bird, Hedley Griffiths, David Nicholls, Maureen Rischmueller, Jane Zochling, Kurt De Vlam, Michel Malaise, Adrien Nzeusseu Toukap, Filip Van den Bosch, Johan Vanhoof, Rubens Bonfiglioli, Mauro Keiserman, Antonio Scafuto Scotton, Ricardo Xavier, Antonio Carlos Ximenes, Assen Atanasov, Ivan Goranov, Ivan Kazmin, Rodina Nestorova Licheva, Nikolay Nikolov, Boycho Oparanov, Rumen Stoilov, Louis Bessette, Jude Rodrigues, Ladislav Bortilik, Eva Dokoupilova, Zdenek Dvoarak, Dagmar Galatikova, Petr Nemec, Lucie Podrazilova, Gabriela Simkova, Zuzana Stejfova, Radka Moravcova, Petr Vitek, Alain Cantagrel, Athan Baillet, Beatrice Banneville, Bernard Combe, Maxime Breban, Minh Nguyen, Philippe Goupille, Juergen Braun, Andrea Everding, Joern Kekow, Ramona Koenig, Andrea Rubbert‐Roth, Torsten Witte, Attila Bartha, Edit Drescher, Kata Kerekes, Attila Kovacs, Judit Pulai, Bernadette Rojkovich, Sandor Szanto, Edit Toth, Hilario Avila, Igancio Garcia Torre, Fedra Irazoque, Marco Maradiaga, Cesar Pacheco, Marek Brzosko, Anna Dudek, Slawomir Jeka, Marek Krogulec, Brygida Kwiatkowska, Piotr Wiland, Rafal Wojciechowski, Agnieszka Zielinska, Helena Santos, Olga Bugrova, Valery Christyakov, Vladimir Gorbunov, Elena Ilivanova, Elena Zemerova, Rima Kamalova, Tatyana Kameneva, Galina Macievskaya, Irina Marusenko, Alexey Maslyansky, Svetlana Myasoedova, Leisan Myasoutova, Boris Nemtsov, Olga Nesmeyanova, Tatyana Plaksina, Tatyana Pokrovskaya, Svetlana Polyakova, Andrey Rebrov, Liudmila Savina, Svetlana Smakotina, Marina Stanislav, Olga Ukhanova, Irina Vinogradova, Elena Zonova, Han Joo Baek, Tae‐Hwan Kim, ChangKeun Lee, SangHeon Lee, Sang‐Hoon Lee, Shin‐Seok Lee, Sung‐Hwan Park, YeongWook Song, Chang‐Hee Suh, Juan Amarelo Ramos, Franciso Javier Blanco, Eduardo Collantes, Miguel Consuelo Diaz, Maria Luz Garcia Vivar, Jordi Gratacos, Xavier Juanola, Der‐Yuan Chen, Hsiang‐Cheng Chen, Kun‐Hung Chen, Ying‐Chou Chen, Ying‐Ming Chiu, Shue‐Fen Luo, Shih‐Tzu Tsai, Jui‐Cheng Tseng, Cheng‐Chung Wei, Meng‐Yu Weng, Orest Abrahamovych, Dmytro Reshotko, Oleksandr Golovchenko, Ihor Hospodarsky, Oleg Iaremenko, Olena Levchenko, Oleksandr Dudnyk, Olena Garmish, Olena Grishyna, Galyna Protsenko, Dmytro Rekalov, Svitlana Smiyan, Mykola Stanislavchuk, Svitlana Trypilka, Vira Tseluyko, Samvel Turianytsia, Viktoriya Vasylets, Nataliya Virstyuk, Yaroslav Kleban, Coziana Ciurtin, Karl Gaffney, Wiranthi Gunasekera, Kirsten Mackay, Jon Packham, Raj Sengupta, Hasan Tahir, Jacob Aelion, Ralph Bennett, Julio Gonzalez‐Paoli, Robert M. Griffin, Michael Grisanti, Jyothi Mallepalli, Eric Peters, Joy Schechtman, Atul Singhal
Publikováno v:
Arthritis and Rheumatology, 71(2), 258-270. WILEY
Deodhar, A; Gensler, LS; Sieper, J; Clark, M; Calderon, C; Wang, Y; et al.(2018). Three Multicenter, Randomized, Double-Blind, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Ustekinumab in Axial Spondyloarthritis.. Arthritis & rheumatology (Hoboken, N.J.). doi: 10.1002/art.40728. UCSF: Retrieved from: http://www.escholarship.org/uc/item/3x5990zb
Arthritis & rheumatology (Hoboken, N.J.), vol 71, iss 2
Deodhar, A; Gensler, LS; Sieper, J; Clark, M; Calderon, C; Wang, Y; et al.(2018). Three Multicenter, Randomized, Double-Blind, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Ustekinumab in Axial Spondyloarthritis.. Arthritis & rheumatology (Hoboken, N.J.). doi: 10.1002/art.40728. UCSF: Retrieved from: http://www.escholarship.org/uc/item/3x5990zb
Arthritis & rheumatology (Hoboken, N.J.), vol 71, iss 2
Author(s): Deodhar, Atul; Gensler, Lianne S; Sieper, Joachim; Clark, Michael; Calderon, Cesar; Wang, Yuhua; Zhou, Yiying; Leu, Jocelyn H; Campbell, Kim; Sweet, Kristen; Harrison, Diane D; Hsia, Elizabeth C; van der Heijde, Desiree | Abstract: Objecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f232b4efcd4d46d6ba1ded5ac5cc76d0
https://doi.org/10.1002/art.40728
https://doi.org/10.1002/art.40728
Autor:
Stephen Xu, Joy Schechtman, Sergio Schwartzman, Aaron Broadwell, S. Kafka, Wayne Langholff, Shawn Black
Publikováno v:
Annals of the Rheumatic Diseases. 80:527.1-528
Background:AWARE is a real-world evidence-based (RWE) study evaluating the safety and efficacy of IV golimumab (GLM) and infliximab (IFX) in adults with RA.Objectives:Evaluate safety and efficacy of IV GLM and IFX in elderly AWARE participants.Method
Autor:
Shirley W. Pang, Michael A. Mont, Shaili Deveshwar, Anton Khlopas, Peter A. Holt, Thomas M. Zizic, Jack S. Tuber, Joy Schechtman, Tuna Ozyurekoglu, Edmund J. Maclaughlin
Publikováno v:
Orthopedics. 41
The hand is commonly affected by osteoarthritis (OA). The development and progression of OA are believed to involve inflammation, even in the early stages of the disease. Inflammatory and proinflammatory cytokines have also been shown to be elevated
Autor:
Marc de Longueville, Joy Schechtman, Elliot Chartash, Michele Texter, Andreas Fichtner, Alan Kivitz
Publikováno v:
The Journal of Rheumatology. 41:648-657
Objective.To evaluate the humoral immune response to pneumococcal and influenza vaccination in adults with rheumatoid arthritis (RA) receiving certolizumab pegol (CZP).Methods.In this 6-week, single-blind, placebo-controlled trial with optional 6-mon
Autor:
Farhad Sedarati, Wolfgang Dummer, Piotr Leszczyński, James Taylor, Joseph E Huffstutter, Dalia Moawad, Joy Schechtman, Marek Brzosko, Amy V Kapp, Rebecca Sudlow
Publikováno v:
International Journal of Clinical Rheumatology. 6:689-696
Aim: To test the hypothesis that a therapeutic dose of ocrelizumab (200 mg × 2), can be administered as a single-infusion (400 mg × 1) to achieve clinical efficacy and safety in patients with active rheumatoid arthritis. Patients & methods: Three h
Autor:
Mark C, Genovese, Jeffrey L, Kaine, Mitchell B, Lowenstein, José, Del Giudice, Andrew, Baldassare, Joy, Schechtman, Edward, Fudman, Michael, Kohen, Sheila, Gujrathi, Robert G, Trapp, Nadera J, Sweiss, Greg, Spaniolo, Wolfgang, Dummer, S, Wolfe
Publikováno v:
Arthritis & Rheumatism. 58:2652-2661
Objective Ocrelizumab, a humanized anti-CD20 monoclonal antibody, was studied in a first-in-human trial in rheumatoid arthritis (RA) patients receiving concomitant methotrexate (MTX). Methods The ACTION trial was a combined phase I/II study of placeb
Autor:
Artur Racewicz, T. Shaw, Arthur Kavanaugh, Anna Filipowicz-Sosnowska, Roy Fleischmann, Ronald F van Vollenhoven, E. W. Hessey, Nicole F. Li, Sunil Agarwal, Joy Schechtman, Paul Emery, Leszek Szczepanski
Publikováno v:
Arthritis & Rheumatism. 54:1390-1400
Objective To examine the efficacy and safety of different rituximab doses plus methotrexate (MTX), with or without glucocorticoids, in patients with active rheumatoid arthritis (RA) resistant to disease-modifying antirheumatic drugs (DMARDs), includi
Autor:
Roy Fleischmann, Gino DiVittorio, Joy Schechtman, Thomas Liu, Alan M. Solinger, John Tesser, Sanford Hartman, Michael Schiff
Publikováno v:
Arthritis & Rheumatism. 50:1752-1760
Objective To determine in a placebo-controlled, double-blind trial the safety profile of daily anakinra (Kineret) use in patients with active rheumatoid arthritis (RA) and concurrent comorbid conditions. Methods In 169 centers in 9 countries, 1,414 p